Head & Neck Cancer Treatment TeamHead & Neck SurgeonsGo back to keep learning about head and neck cancer expertsHead & Neck Radiation OncologistsGo back to keep learning about head and neck cancer ...

Research at MSK Our research impact Research topics Core facilities & resources ...

The lab of MSK cancer immunologist Dr. Andrea Schietinger and colleagues at Weill Cornell Medicine found that a small subset of T cells, called stem T cells, are responsible for m ...

Memorial Sloan Kettering medical oncologist Steven Maron specializes in treating cancers of the gastrointestinal tract. His research is focused on improving treatments for esophageal and stomach ...

What are the foods to avoid on the bland diet? Stay away from these items: spicy or highly seasoned foods, such as curry, hot sauce, hot peppers, and onions high-fat foods, such as red meat, cream, ...

Immunotherapy drugs use your own immune system to fight disease. These drugs have improved treatment for many types of cancer. Still, immunotherapy does not work for everyone. Whether these drugs work ...

Research at MSK Our research impact Research topics Core facilities & resources ...

DNA replication, repair, and damage response, collectively called the 3Rs, support genome stability and faithful genetic inheritance. Proteins involved in the 3Rs are genome guardians that prevent a ...

2. Why is pancreatic cancer hard to diagnose early? Pancreatic cancer usually does not cause symptoms in its early stages. Some that do occur — such as pain or weight loss — can often be mistaken for ...

MSK physician-scientists Dr. Viviane Tabar and Dr. Lorenz Studer have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them ...

MSK gastrointestinal medical oncologist Eileen O'Reilly, MD (left), led a very promising early phase clinical trial of the targeted RAS therapy daraxonrasib for people facing pancreatic cancer, ...

MSK gastrointestinal medical oncologist Dr. Wungki Park led the early phase clinical trial of daraxonrasib for people with metastatic pancreatic cancer that had stopped responding to chemotherapy.